Energy Expenditure and Quality of Life in Epilepsy
Key facts
- Who runs it
- University of Wisconsin, Madison
- Where
- Madison, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- Jun 2023
- Ended
- Aug 2025
- Type of study
- Observational
- Treatments tested
- Ketogenic Diet
- Record updated
- 29 June 2023
- Why it stopped
- decided not to process with study
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- aged 18-45
- Diagnosis of epilepsy
- Experience an average of 2 or more seizures per month during the 3 months prior to study
- Plan to start oral ketogenic diet therapy (e.g. with the modified Atkins diet)
- Have low average or higher cognitive/intellectual function and are able to complete self-report questionnaires
- over 18 years of age (no age limit)
- Diagnosis of epilepsy
- Experience an average of 2 or more seizures per month during the 3 months prior to study
- Plan to start oral ketogenic diet therapy (e.g. with the modified Atkins diet)
- Have low average or higher cognitive/intellectual function and are able to complete self-report questionnaires
Who cannot take part
- Currently using medications that may cause metabolic and/or absorptive alterations (e.g. diuretics, amphetamines, lipase inhibitors, corticosteroids, etc.)
- Already on ketogenic therapy
- Presence of edema, conditions or persistent side effects of medication use (e.g. vomiting, diarrhea, excessive sweating, and burns) that could cause alterations in the body hydration and consequently, be a bias in energy metabolism variables
- Liver, kidney, or pancreatic disease
- Fatty acid oxidation disorder or pyruvate carboxylase deficiency
- Unstable metabolic condition (e.g. persistent sodium <130 or glucose <50)
- Participants who report being claustrophobic
- Hypercholesterolemia (cholesterol > 300mg/dL)
- Currently pregnant or planning on becoming pregnant
Where in United States
- University of WisconsinMadison, United States
About the trial
What the trial wants to find out
The main objectives of this study are to investigate the influence of the ketogenic diet (KD), standard care for patients assisted in the UW Health Adult Epilepsy Dietary Therapy Clinic, on changes in the frequency and severity of seizures, QoL, energy substrate metabolism, body energy expenditure components, fat mass and fat-free mass in adults with epilepsy. To achieve this objective, twenty-five male and female participants between the ages of 18 and 45 years (or over 18 years for remote participation), who accepted to initiate the KD as a standard of care prescribed by their physician, will be recruited according to inclusion/exclusion criteria. Participants will be on study for 6 months.
The group in the trial
- Ketogenic Diet
* Baseline Assessments * Ketogenic diet intervention * 3 and 6 month Assessments
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Ketogenic Diet on Epilepsy: Metabolism and Quality of Life
- Record updated
- 29 June 2023